SALARIUS PHARMACEUTICALS INC's ticker is SLRX and the CUSIP is 79400X107. A total of 35 filers reported holding SALARIUS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $28,000 | -6.7% | 142,552 | 0.0% | 0.00% | – |
| Q2 2022 | $30,000 | -47.4% | 142,552 | 0.0% | 0.00% | – |
| Q1 2022 | $57,000 | -19.7% | 142,552 | 0.0% | 0.00% | – |
| Q4 2021 | $71,000 | -51.0% | 142,552 | 0.0% | 0.00% | – |
| Q3 2021 | $145,000 | -4.0% | 142,552 | 0.0% | 0.00% | – |
| Q2 2021 | $151,000 | – | 142,552 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Laird Norton Wetherby Wealth Management, LLC | 39,746 | $150,000 | 0.02% |
| Douglass Winthrop Advisors, LLC | 78,806 | $298,000 | 0.01% |
| Financial Advocates Investment Management | 11,472 | $43,000 | 0.01% |
| NEXT Financial Group, Inc | 20 | $0 | 0.00% |
| Advisor Group, Inc. | 1,900 | $7,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 36,660 | $138,000 | 0.00% |
| BlackRock Inc. | 1,197 | $4,000 | 0.00% |
| JPMORGAN CHASE & CO | 13 | $0 | 0.00% |
| MORGAN STANLEY | 1,598 | $6,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 8,563 | $32,000 | 0.00% |